OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Heart and Lung Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Information for Readers	526
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	348
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	316
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	212
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	159
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	150
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	118
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	110
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner	87
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)	83
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?	77
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	72
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	71
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	65
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	64
Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation	60
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	59
Hemodynamic Modeling for Mitral Regurgitation	58
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis	58
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	55
Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database	53
Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients	50
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	48
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	48
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	47

ISHLT 2023 Author Index	46
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	46
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	46
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	46
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	43
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	43
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil	42
Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic	41
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	41
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	41
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	39
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	39
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	38
Argon Inhalation Reduces Pulmonary Ischemia-Reperfusion Injury in MHC-inbred CLAWN Miniature Swine	38
When a Single Choice Impacts a Single Ventricle: Paracorporeal Pediatric VAD Support at 544 Days	37
Pulmonary Hypertension and Diastolic Heart Failure in an Adolescent African-American Cantú Syndrome Patient	37
The Normalised Acute Rejection Score in the First Year Post Transplant and Its Association with CLAD	37
Hypogammaglobinemia in Patients Palliated with the Fontan Circulation: Implications for Cardiac Transplantation	36
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	36
Comparison of LVAD Admissions Before and During the Era of COVID-19	36
Sequential Double-Lung Transplantation in Kartagener Syndrome: A Case Report	35
Hemodynamic Implications of Sildenafil in Candidates for Heart Transplantation with Group 2 Pulmonary Hypertension: A Single Latin-American Center Registry	35
(911) Older Donors in Lung Transplantation: The Portuguese Experience	35
Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment	35
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR	33
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score	33
Safety of Single Lung Transplantation Post Donation Service Area-Specific Organ Distribution	33
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	32
Kidney Transplantation in Single Ventricle Palliated Patients: A Pediatric Cardiac Care Consortium Study	32
Immune Characterization of a Xenogeneic Cross Circulation System for Ex Vivo Human Lung Support	31
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	31
Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients	31
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	30
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	29
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	29
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	28
Information for Readers	28
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	28
Utility of Breath Volatomic Analysis in Lung Transplant Recipients	28
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	28
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	28
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	28
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	28
Not just for the birds: The emerging role of B cells in transplant immunology	27
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	27
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	27
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	27
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	27
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	26
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	26

Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	26
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	26
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	25
Early Onset Malignancy in the First-Year After Heart Transplantation	25
Older Donor Hearts for Heart Transplantation	25
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	25
WITHDRAWN	25
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	25
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	25
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	25
Editorial Board	24
Comparative Analysis of Fontan Transplant Outcomes	24
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	23
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	23
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	23
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	23
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	23
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	23
Table of Contents	23
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	23
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	22
Imaging Mass Cytometry for Detailed Cellular and Spatial Characterization of Chronic Lung Allograft Dysfunction (CLAD)	22
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?	22
Lactic Acid and Metabolic Analysis of Human Donor Hearts Preserved with Organ Care System	22
Ex-vivo lung perfusion: National trends and post-transplant outcomes	22
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	22
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	22
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	22
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	22
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	22
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	22
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	21
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial	21
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	21
Extra-cardiac management of cardiogenic shock in the intensive care unit	21
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	21
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	21
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	21
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	20
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	20
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	20
Impact of Logistic Challenges on Cardiac Transplantation	20
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	20
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	20
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation	20
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	20
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	20
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	20
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	19
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	19
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	19
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	19
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	19
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	19
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	19
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	19
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	19
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	18
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	18
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	18
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	18
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	18
Use of Heart in Donor Death Caused by Lightning	18
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	17
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	17
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	17
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	17
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	17
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	17
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	17
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	17
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	17
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	17
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	17
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	17
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	17
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	16
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	16
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	16
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	16

Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant	16
DCD Heart Transplantation with NRP: Excellent Results and a Continued Uphill Battle	16
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	16
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	16
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	16
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	16
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	16
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	16
Extending the Bridge, Bridging the Gap	16
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	16
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	16
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	16
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	16
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	16
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	16
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	16
Life on the driveline: Still finding traction in improving transplant outcomes for children with myocarditis	15
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	15
Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine	15
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation	15
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume	15
I got it from my mamma: Sensitization by transplacental transfer of maternal HLA antibodies managed with manual exchange transfusion	15
Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation	15
Risk of Prolonged Intubation Post-Pediatric Heart Transplantation	15
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	15
Coronavirus disease 2019 outcomes in heart transplant recipients: A large Australian cohort	15
First North American Experience with The Berlin Heart Active Driver	15
Towards a nuanced understanding of donor risk	15
Incidence and Risk Factors for Early Stroke Following Durable Left Ventricular Assist Device (LVAD) Implantation: An STS Intermacs Analysis	15
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients	15
Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document	14
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial	14
Eplet Matching in Pediatric Heart Transplantation	14
(550) A Retrospective Study on Gender, LAA Morphology and Stroke Risk	14
(559) Heart Transplantation Using Super Aged Donors at 65 Years and Over	14
(771) Post-Implant Outcomes in Diabetic vs. Non-Diabetic Durable LVAD Patients	14
Standardized Radiographic Evaluation of Human Donor Lungs During Ex Vivo Lung Perfusion Predicts Lung Injury and Lung Transplant Outcomes	14
(817) Lvad-Stem Cell Combination Therapy in Non-Ischemic Dilated Cardiomyopathy Patient: Case Report	14
Artificial Intelligence for the Prognostication and Management of Heart Transplant: A Scoping Review	14
Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review	14
Gentle Giant: An Unusual Cause of Heart Block	14
VAD as Bridge to Transplant Decision in Nine-Year-Old Child with Duchenne Muscular Dystrophy	14
A Rare Case of ACE Inhibitor-Induced Intestinal Angioedema Presenting as a Delayed Complication in a Heart Transplant Recipient	14
(1191) Diagnostic Utility of Surveillance Transbronchial Biopsies after the First Post-Lung Transplant Year	14
Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial	14
Rapid progression of cardiac remodeling and apical wall thinning in early age with hypertrophic cardiomyopathy	14
The Role of Anti-Thymocyte Globulin in Peri-Operative Desensitization for Donor Specific Antibody Positive Lung Transplants	14
The United States Experience of Lung Transplantation in Recipients with COVID-19 Fibrosis: A UNOS/OPTN Analysis	14
Peri-Operative Warfarin Protocol to Decrease Length of Stay After Left Ventricular Assist Device Implantation	14
Development of De-Novo Aortic Insufficiency in Patients with Durable Left Ventricular Assist Device Who Were Bridged from Impella Device	14
Care Close to Home: Justification for a Second Paediatric Heart Transplant Centre in Australia	14
(647) Utilization of Hepatitis C Virus Infected Donor in Heart Transplant Recipients with Elevated Meld-Xi Score	13
(612) Using the SCAI Classification for Early Identification and Real-Time Monitoring of Cardiogenic Shock Patients	13
(634) Is Off-Pump Coronary Bypass Surgery the Savior of Low EF Coronary Artery Disease Patients?	13
Body Mass Index and Cause-Specific Mortality After Lung Transplantation in the United States	13
(859) Concurrent Tracheobronchoplasty and Bilateral Lung Transplant for Obstructive Lung Disease	13
(921) Effect of Surgical Exposure on Short-Term Outcomes after Bilateral Lung Transplantation	13
(686) West Nile Virus Meningoencephalitis in a Bilateral Lung Transplant Recipient	13
Scimitar Syndrome Outcomes in Patients with Pulmonary Hypertension: A Single Center Experience	13
Low AlloSure® in HeartCare® Associated with Low Risk of Significant Allograft Rejection: An Analysis of SHORE	13
(730) Continuous Temperature Measurements in Donor Hearts During Cold Organ Procurement	13
Longitudinal Echocardiographic Assessment of Donor Hearts in DCD Donors Using Thoracoabdominal Normothermic Regional Perfusion	13
PET Scan for CAV Screening in Heart Transplant Patients: A Real World Experience	13
Risks and Outcomes Associated with Pleural Space Infections After Lung Transplantation	13
Pulmonary Dead Space Fraction: A Predictive Factor for Transplant Suitability in Clinical Ex Vivo Lung Perfusion	13
(826) Dual VADs to Dual Organs: Successful Bridge to Heart and Kidney Transplantation with 2 HeartMate 3 LVADs in Biventricular Failure	13
Outcomes of Mechanical Circulatory Support for Severe Primary Graft Dysfunction After DBD versus DCD Heart Transplantation	13
(691) Right Heart Recovery after Lung Transplantation in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome: A Cohort Study	13
Long-Term Weaning of Mechanical Ventilation After Lung Transplantation: Patient Characteristics and Impact on Survival	13
(916) Lung Transplant Outcomes in Young Adults with Pulmonary Hypertension Bridged with ECMO	13
(711) Capillary Leak Syndrome Induced by Tacrolimus in Post-Lung Transplant Recipient	13
(179) Clinical Predictors of 5-year Outcomes Following Heartmate 3 Left Ventricular Assist Device Implant: The Momentum 3 Trial	12
Pulmonary Artery Pressures During Cardiopulmonary Exercise Testing Using Cardiomems	12
Small Anastomotic Dehiscence Identified Late After Lung Transplant	12
(1246) Novel Regional Ventilation Evaluation of Abnormalities of the Lung In Advanced Lung Disease (REVEAL Study)	12
Using mTOR Inhibitor Nanoimmunotherapy to Induce Cardiac Allograft Tolerance in Non-Human Primates	12
(933) Mechanical Circulatory Support as a Weaning Platform from Extracorporeal Membrane Oxygenation	12
(1272) Effect of Aging on the Progression of Pulmonary Ischemia-Reperfusion Injury in Clawn Miniature Swine	12
(439) Severe Biventricular Dysfunction Following Pericardiectomy in a Pediatric Patient	12
(1013) The Dilemma of the Role of Non-HLA Antibodies in AMR	12
Proposal for Simplified Endoscopic Standardized Grading of Central Airway Complications After Lung Transplantation According to the Long-Term Prognosis Value of the Current MDS Classification	12
Intercostal Nerve Cryoablation as Part of an Opioid-Sparing Protocol Reduces Narcotic and Epidural Use After Lung Transplant	12
(1247) Rapidly Declining Rates of Single Lung Transplant for COPD and ILD in the U.S	12
(158) Association of SIPAT Score with Long-Term Psychosocial and Clinical Outcomes in Orthotopic Heart Transplant Recipients	12
Youth Perspectives on Life and Healthcare After Lung Transplant	12
(1014) Super Accelerated Cardiac Allograft Vasculopathy	12
Donor and Peri-Transplant Hospitalization Risk Factors for Invasive Fungal Infection in Lung Transplant Recipients	12
(956) Chronic in Vivo Animal Data on a Wireless Systolic Synchronized Mini-Cardiac Pump	12
(162) A Multicenter Randomized Placebo-Controlled Trial of Intravenous Thyroxine for Heart-Eligible Brain-Dead Organ Donors	12
TOC - CMYK color build of red	11
Clinician Assessed Versus Objective Measures of Frailty in Left Ventricular Assist Device Patients	11
Intravascular Volume Derangement and Value of Blood Volume Analysis in Stable Ambulatory Patients with Advanced Heart Failure Supported with Left Ventricular Assist Device	11
Donation After Circulatory Death Heart Transplantation with Ex-Vivo Perfusion: Is It Ready for Prime Time?	11
Triheptanoin Use for Severe Neonatal Cardiomyopathy Secondary to Mitochondrial Trifunctional Protein Deficiency- A First Report	11
(1116) Pediatric Heart Failure Program Development-Evaluation of a Single Center Experience	11